Regulators extend shelf life of Valneva's Covid vaccine candidate

Vaccines company Valneva said on Thursday that its inactivated COVID-19 vaccine candidate product VLA2001 had its shelf life extended to 21 months from 18 months previously, as it unveiled regulatory updates for the product.

Reuters

Updated:2nd Mar, 2023 at 7:39 PM

PARIS: Vaccines company Valneva said on Thursday that its inactivated COVID-19 vaccine candidate product VLA2001 had its shelf life extended to 21 months from 18 months previously, as it unveiled regulatory updates for the product.

“As previously announced, Valneva will not invest in further development of the vaccine, in the absence of a new partnership. It is, however, completing remaining clinical studies and submissions as agreed with regulators,” added Valneva.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

SCROLL FOR NEXT

Regulators extend shelf life of Valneva's Covid vaccine candidate

Vaccines company Valneva said on Thursday that its inactivated COVID-19 vaccine candidate product VLA2001 had its shelf life extended to 21 months from 18 months previously, as it unveiled regulatory updates for the product.

Also Read

Digital route overtakes cash in Tamil Nadu bribe deals, DVAC data shows

‘Gold is Radha’s weakness’: Ambika refutes Rs 46 crore cheque fraud allegations

How Chennai police tried to drop Pocso case against mining baron Veeramani in February

IIT Bombay alumni seek fair probe into student's suicide, appeal against 'media trial'

US announces USD 31 million support for flood-hit Nepal